Aortic stenosis assessment from the 3-chamber cine: ratio of balanced steady-state-free-precession (bSSFP) blood signal between the aorta and left ventricle predicts severity.

Aortic Stenosis Aortic Valve Balanced Steady-State Free Precession Left Ventricle Magnetic Field Strength Valvular heart disease

Journal

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
ISSN: 1532-429X
Titre abrégé: J Cardiovasc Magn Reson
Pays: England
ID NLM: 9815616

Informations de publication

Date de publication:
09 Jan 2024
Historique:
received: 01 12 2023
accepted: 10 12 2023
medline: 12 1 2024
pubmed: 12 1 2024
entrez: 11 1 2024
Statut: aheadofprint

Résumé

Cardiovascular magnetic resonance (CMR) imaging is an important tool for evaluating the severity of aortic stenosis (AS), co-existing aortic disease, and concurrent myocardial abnormalities. Acquiring this additional information requires protocol adaptations and additional scanner time, but is not necessary for the majority of patients who do not have AS. We observed that the relative signal intensity of blood in the ascending aorta on a balanced steady state free precession (bSSFP) 3-chamber cine was often reduced in those with significant aortic stenosis. We investigated whether this effect could be quantified and used to predict AS severity in comparison to existing gold-standard measurements. Multi-centre, multi-vendor retrospective analysis of patients with AS undergoing CMR and transthoracic echocardiography (TTE). Blood signal intensity was measured in a ~1cm 314 patients (median age 69 [IQR 57-77], 64% male) who had undergone both CMR and TTE were studied; 84 had severe AS, 78 had moderate AS, 66 had mild AS and 86 without AS were studied as a comparator group. The median time between CMR and TTE was 12 weeks (IQR 4-26). The Ao:LV ratio at 1.5T strongly correlated with peak velocity (r = -0.796, p=0.001), peak gradient (r = -0.772, p=0.001) and dimensionless index (r = 0.743, p = 0.001). An Ao:LV ratio of <0.86 was 84% sensitive and 82% specific for detecting AS of any severity and a ratio of 0.58 was 83% sensitive and 92% specific for severe AS. The ability of Ao:LV ratio to predict AS severity remained for patients with bicuspid aortic valves, dilated aortic root or low indexed stroke volume. The relationship between Ao:LV ratio and AS severity was weaker at 3T. The Ao:LV ratio, derived from bSSFP 3-chamber cine images, shows a good correlation with existing measures of AS severity. It demonstrates utility at 1.5T and offers an easily calculable metric that can be used at the time of scanning or automated to identify on an adaptive basis which patients benefit from dedicated imaging to assess which patients should have additional sequences to assess AS.

Sections du résumé

BACKGROUND BACKGROUND
Cardiovascular magnetic resonance (CMR) imaging is an important tool for evaluating the severity of aortic stenosis (AS), co-existing aortic disease, and concurrent myocardial abnormalities. Acquiring this additional information requires protocol adaptations and additional scanner time, but is not necessary for the majority of patients who do not have AS. We observed that the relative signal intensity of blood in the ascending aorta on a balanced steady state free precession (bSSFP) 3-chamber cine was often reduced in those with significant aortic stenosis. We investigated whether this effect could be quantified and used to predict AS severity in comparison to existing gold-standard measurements.
METHODS METHODS
Multi-centre, multi-vendor retrospective analysis of patients with AS undergoing CMR and transthoracic echocardiography (TTE). Blood signal intensity was measured in a ~1cm
RESULTS RESULTS
314 patients (median age 69 [IQR 57-77], 64% male) who had undergone both CMR and TTE were studied; 84 had severe AS, 78 had moderate AS, 66 had mild AS and 86 without AS were studied as a comparator group. The median time between CMR and TTE was 12 weeks (IQR 4-26). The Ao:LV ratio at 1.5T strongly correlated with peak velocity (r = -0.796, p=0.001), peak gradient (r = -0.772, p=0.001) and dimensionless index (r = 0.743, p = 0.001). An Ao:LV ratio of <0.86 was 84% sensitive and 82% specific for detecting AS of any severity and a ratio of 0.58 was 83% sensitive and 92% specific for severe AS. The ability of Ao:LV ratio to predict AS severity remained for patients with bicuspid aortic valves, dilated aortic root or low indexed stroke volume. The relationship between Ao:LV ratio and AS severity was weaker at 3T.
CONCLUSIONS CONCLUSIONS
The Ao:LV ratio, derived from bSSFP 3-chamber cine images, shows a good correlation with existing measures of AS severity. It demonstrates utility at 1.5T and offers an easily calculable metric that can be used at the time of scanning or automated to identify on an adaptive basis which patients benefit from dedicated imaging to assess which patients should have additional sequences to assess AS.

Identifiants

pubmed: 38211656
pii: S1097-6647(23)00170-9
doi: 10.1016/j.jocmr.2023.100005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100005

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Competing interests The authors declare that they have no competing interests.

Auteurs

Kavitha Vimalesvaran (K)

A1 for Healthcare Centre for Doctoral Training, Imperial College London, SW7 2AZ, United Kingdom; National Heart and Lung Institute, Imperial College London, SW7 2AZ, United Kingdom; Imperial College Healthcare NHS Trust, London, W12 0HS United Kingdom. Electronic address: k.vimalesvaran@imperial.ac.uk.

Sameer Zaman (S)

National Heart and Lung Institute, Imperial College London, SW7 2AZ, United Kingdom; Imperial College Healthcare NHS Trust, London, W12 0HS United Kingdom. Electronic address: sameer.zaman10@imperial.ac.uk.

James P Howard (JP)

National Heart and Lung Institute, Imperial College London, SW7 2AZ, United Kingdom; Imperial College Healthcare NHS Trust, London, W12 0HS United Kingdom. Electronic address: james.howard1@imperial.ac.uk.

Nikoo Aziminia (N)

Barts Heart Centre, Barts Health NHS Trust, West Smithfield, London EC1A 7BE, United Kingdom. Electronic address: nikoo.aziminia@nhs.net.

Marilena Giannoudi (M)

Multidisciplinary Cardiovascular Research Centre & Department of Biomedical Imaging Science, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds LS2 9JT, United Kingdom. Electronic address: m.giannoudi@leeds.ac.uk.

Henry Procter (H)

Multidisciplinary Cardiovascular Research Centre & Department of Biomedical Imaging Science, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds LS2 9JT, United Kingdom. Electronic address: h.procter@leeds.ac.uk.

Marta Varela (M)

National Heart and Lung Institute, Imperial College London, SW7 2AZ, United Kingdom. Electronic address: marta.varela@imperial.ac.uk.

Fatmatulzehra Uslu (F)

Department of Electric-Electronic Engineering, Bursa Technical University, Bursa, Türkiye. Electronic address: fatmatulzehra.uslu@btu.edu.tr.

Ben Ariff (B)

Imperial College Healthcare NHS Trust, London, W12 0HS United Kingdom. Electronic address: b.ariff@nhs.net.

Nick Linton (N)

Imperial College Healthcare NHS Trust, London, W12 0HS United Kingdom; Department of Bioengineering, Imperial College London, SW7 2AZ United Kingdom. Electronic address: nick.linton@imperial.ac.uk.

Eylem Levelt (E)

Multidisciplinary Cardiovascular Research Centre & Department of Biomedical Imaging Science, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds LS2 9JT, United Kingdom. Electronic address: e.levelt@leeds.ac.uk.

Anil A Bharath (AA)

Imperial College Healthcare NHS Trust, London, W12 0HS United Kingdom; Department of Bioengineering, Imperial College London, SW7 2AZ United Kingdom. Electronic address: a.bharath@imperial.ac.uk.

Graham D Cole (GD)

National Heart and Lung Institute, Imperial College London, SW7 2AZ, United Kingdom; Imperial College Healthcare NHS Trust, London, W12 0HS United Kingdom. Electronic address: graham.cole3@nhs.net.

Classifications MeSH